Cargando…

A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson’s Disease Quantification

OBJECTIVES: [18F]9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]-FP-DTBZ) positron emission tomography (PET) provides reliable information for the diagnosis of Parkinson’s disease (PD). In this study, we proposed a multi-atlas-based [18F]-FP-DTBZ PET image segmentation method for PD quantification as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yiwei, Liu, Shuying, Zeng, Yao, Ye, Chenfei, Qiao, Hongwen, Song, Tianbing, Lv, Haiyan, Chan, Piu, Lu, Jie, Ma, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234266/ https://www.ncbi.nlm.nih.gov/pubmed/35769601 http://dx.doi.org/10.3389/fnagi.2022.902169

Ejemplares similares

PET Imaging a MPTP-Induced Mouse Model of Parkinson’s Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [(18)F]-DTBZ (AV-133)
por: Toomey, James S., et al.
Publicado: (2012)

Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo (18)F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging
por: Weng, Chi-Chang, et al.
Publicado: (2017)

Corrigendum: Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson's disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Radiosynthesis and Analysis of (S)-4-(3-[(18)F]Fluoropropyl)-L-Glutamic Acid
por: Brown, Gavin, et al.
Publicado: (2022)

Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[(18)F]fluoropropyl)-L-glutamic acid ([(18)F]FSPG) for clinical use
por: Shih, Kai-Ting, et al.
Publicado: (2020)

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
por: Skor, Heather, et al.
Publicado: (2017)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
por: Wu, Zehui, et al.
Publicado: (2014)

Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2021)

Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
por: Díaz-Álvarez, Josefa, et al.
Publicado: (2022)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023)

Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy
por: Finze, Anika, et al.
Publicado: (2022)

Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer’s disease defined by fluorodeoxyglucose-positron emission tomography
por: Kato, Takashi, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of O-[3-(18)F-fluoropropyl]-α-methyl Tyrosine in Mesothelioma-Bearing Rodents
por: Shih, I-Hong, et al.
Publicado: (2013)

Tumor Quantification in Clinical Positron Emission Tomography
por: Bai, Bing, et al.
Publicado: (2013)

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
por: Mittra, Erik S., et al.
Publicado: (2016)

(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia
por: Wang, Wenyan, et al.
Publicado: (2021)

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023)

Comparison of different quantification methods for (18)F-fluorodeoxyglucose-positron emission tomography studies in rat brains
por: Prando, Silvana, et al.
Publicado: (2019)

Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes
por: Lobon, Irene, et al.
Publicado: (2022)

Positron Emission Tomography in the Differential Diagnosis of Parkinsonism
por: Rinne, Juha O
Publicado: (2009)

Top and bottom longevity of nations: a retrospective analysis of the age-at-death distribution across 18 OECD countries
por: Verguet, Stéphane, et al.
Publicado: (2022)

Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson’s disease
por: Li, Tianbai, et al.
Publicado: (2020)

Editorial: Advances in connectome-wide association studies (CWAS) along the neurodegeneration trajectory
por: Ye, Chenfei, et al.
Publicado: (2023)

Genetic analysis of dystonia-related genes in Parkinson's disease
por: Wang, Yige, et al.
Publicado: (2023)

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
por: Yang, YoungSoon, et al.
Publicado: (2017)

Cortical gyrification pattern of depression in Parkinson’s disease: a neuroimaging marker for disease severity?
por: Shen, Qin, et al.
Publicado: (2023)

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Automatic lesion detection and segmentation in (18)F-flutemetamol positron emission tomography images using deep learning
por: Ryu, Chan Ju
Publicado: (2022)

Abnormalities in the Fractional Amplitude of Low-Frequency Fluctuation and Functional Connectivity in Parkinson's Disease With Excessive Daytime Sleepiness
por: Zi, Yuheng, et al.
Publicado: (2022)

An account of data entry inconsistencies and their impact on positron emission tomography quantification
por: Nguyen, Tram, et al.
Publicado: (2018)

Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography
por: Chen, Haojun, et al.
Publicado: (2017)

Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography
por: Balcerzyk, Marcin, et al.
Publicado: (2020)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Feasibility evaluation of middle-phase (18)F-florbetaben positron emission tomography imaging using centiloid quantification and visual assessment
por: Wu, Cheng-Han, et al.
Publicado: (2023)

(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Asymmetric (18)F-fluorination for applications in positron emission tomography
por: Buckingham, Faye, et al.
Publicado: (2016)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18d5cal0posl8e8esa59gj1i3b